Cresset Asset Management’s TC BioPharm (Holdings) plc American Depositary Shares TCBP Stock Holding History

Cresset Asset Management’s Portfolio TCBP Stock Details TCBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-8	Closed	-$10.8K	–	1937
2023 Q3	$10.8K	Buy	+8	New	+$13.2K	﹤0.01%	1790

Other funds holding TCBP

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cresset Asset Management's TCBP Position: Q4 2023 in Review

Cresset Asset Management sold out of TC BioPharm (Holdings) plc American Depositary Shares (TCBP) in Q4 2023, closing a stake of 8 shares — an estimated $10.8K sold.

Cresset Asset Management first reported a position in TCBP in Q3 2023 and held it in 1 quarter. The position peaked at $10.8K in Q3 2023. 3 funds tracked by Wall St. Rank hold TCBP as of Q4 2023.

Cresset Asset Management reported no remaining TC BioPharm (Holdings) plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
Cresset Asset Management sold 8 TC BioPharm (Holdings) plc American Depositary Shares shares in Q4 2023, an estimated $10.8K.
Cresset Asset Management first reported a position in TC BioPharm (Holdings) plc American Depositary Shares in Q3 2023 and held it in 1 quarter.
Cresset Asset Management's TC BioPharm (Holdings) plc American Depositary Shares position peaked at $10.8K in Q3 2023.
3 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc American Depositary Shares as of Q4 2023.

Based on Cresset Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.